Get the Stockscreener App
31.42
0.70%
-0.22
After Hours:
31.42
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $31.42, with a volume of 4.11M.
It is down -0.70% in the last 24 hours and up +6.51% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
See More
Previous Close:
$31.64
Open:
$31.51
24h Volume:
4.11M
Relative Volume:
0.93
Market Cap:
$16.04B
Revenue:
$17.28B
Net Income/Loss:
$108.00M
P/E Ratio:
157.10
EPS:
0.2
Net Cash Flow:
$391.00M
1W Performance:
-3.88%
1M Performance:
+6.51%
6M Performance:
-10.92%
1Y Performance:
-19.39%
1-Day Range:
$31.21
$31.59
1-Week Range:
$30.63
$33.32
52-Week Range:
$28.34
$44.01
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(847) 948-2000
Address
ONE BAXTER PKWY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
31.42 | 16.04B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
579.65 | 206.74B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
242.42 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.57 | 45.29B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
240.46 | 35.33B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
331.04 | 24.01B | 2.88B | 499.60M | 321.60M | 6.74 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter International Inc. (NYSE:BAX) Short Interest Up 30.4% in January - MarketBeat
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
Baxter International Stock: Is Wall Street Bullish or Bearish? - Nasdaq
José Almeida retires as Baxter CEO, president and chair - Yahoo Finance
Baxter CEO Jose Almeida to retire after near decade-long tenure - ETHRWorld.com
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company - GlobeNewswire
Baxter International's CEO José Almeida retires - MSN
Baxter International Inc.: A Possible Value Trap (NYSE:BAX) - Seeking Alpha
Vantive Korea debuts following Carlyle's acquisition of Baxter's kidney care unit - KBR
Forsta AP Fonden Raises Stock Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter announces CEO’s immediate retirement, days after $3.7 billion sale of kidney care business - MSN
Baxter names new Senior VP and Chief Accounting Officer - MSN
Baxter announces CEO’s immediate retirement, days after $3.7B sale of kidney care business - Chicago Tribune
SG Americas Securities LLC Acquires 8,179 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter: CEO Retires Suddenly, While Tariffs Create Another Profit Hurdle - Morningstar
Baxter's 2025 Guidance Looks Likely to Be Cut Because of New Tariffs - Morningstar
Baxter CEO José Almeida to retire after near decade-long tenure - Reuters
Baxter Unit Beats Fresenius Attack On Dialysis Patent - Law360
Baxter CEO Retires; Company Appoints COO - MPO-mag
Baxter CEO José Almeida to retire, effective immediately - Fierce Biotech
Baxter completes $3.8B sale of renal care biz, shakes up C-suite - BioWorld Online
Baxter CEO abruptly retires - Crain's Chicago Business
Baxter International Announces Leadership Transition and Appointments - TipRanks
Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group -February 03, 2025 at 08:40 am EST - Marketscreener.com
Baxter CEO Almeida to retire, Kidney Care business becomes standalone company - Mass Device
Baxter International Weighing Potential Tariff Impact -February 03, 2025 at 08:24 am EST - Marketscreener.com
Baxter International Inc. (BAX) Completes Strategic Divestiture of Vantive Health LLC - GuruFocus.com
Baxter completes $3.8 billion assets sale to Spruce Bidco - Investing.com
Baxter Chief Executive Retires; Brent Shafer Named Interim CEO -February 03, 2025 at 08:06 am EST - Marketscreener.com
Baxter International Weighing Potential Tariff Impact - MarketWatch
Baxter International Chairman, President, CEO Jose Almeida Retires - The Wall Street Journal
Baxter International’s Strategic Divestment and Leadership Changes - TipRanks
Baxter Kidney Care becomes Vantive following acquisition by Carlyle funds - TipRanks
Baxter International's CEO José Almeida retires By Investing.com - Investing.com Australia
Baxter Announces Retirement of CEO, José Almeida - citybiz
Baxter Announces CEO Retirement and Appointment of COO - The Bakersfield Californian
Baxter International Announces New Chief Accounting Officer - MSN
Baxter International Inc. (NYSE:BAX) Shares Sold by Pacer Advisors Inc. - MarketBeat
Baxter names new Senior VP and Chief Accounting Officer By Investing.com - Investing.com Canada
Earnings Preview: What To Expect From Baxter International's Report - MSN
Baxter International Inc. Announces Executive Changes -January 31, 2025 at 04:58 pm EST - Marketscreener.com
Baxter International Inc. (BAX) Appoints New Chief Accounting Of - GuruFocus.com
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International: An Uncompelling Investment With High Debt - Seeking Alpha
Baxter's Hurricane-Hit IV Fluid Factory Has Restarted All Manufacturing Lines - Yahoo Finance
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus.com
Biological Drugs Strategic Research Report 2024-2030, - GlobeNewswire
Biological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer - GlobeNewswire Inc.
Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet? - Simply Wall St
Baxter International Inc. (NYSE:BAX) Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):